You have 9 free searches left this month | to do more
Showing 26 - 50 of
1,410 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Not yet recruiting
  • SARS-CoV2
  • COVID-19
  • Ankara, Cebeci, Turkey
  • +3 more
2021-04-01
Apr 1, 2021
H
Recruiting
  • Chronic Hepatitis C
  • Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
  • Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
  • Cairo, Egypt
    Faculty of medicine Helwan University
2021-01-03
Jan 3, 2021
M
Completed
  • Chronic Hepatitis C Genotype 1
  • (no location specified)
2021-01-15
Jan 15, 2021
S
Terminated
  • Birth Defects
  • +2 more
    • Wilmington, North Carolina
      INC Research, LLC
    2020-12-10
    Dec 10, 2020
    N
    Completed
    • HIV Infections
    • Hepatitis C
    • New York, New York
    • +1 more
    2021-10-28
    Oct 28, 2021
    N
    Completed
    • HIV Infections
    • Hepatitis C
    • Ribavirin
    • +2 more
    • Los Angeles, California
    • +7 more
    2021-10-28
    Oct 28, 2021
    N
    Completed
    • HIV Infections
    • Washington, District of Columbia
    • +14 more
    2021-10-27
    Oct 27, 2021
    A
    Completed
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin
    • (no location specified)
    2021-07-08
    Jul 8, 2021
    D
    Completed
    • Chronic Hepatics C Virus (HCV) Genotype 1
    • +3 more
    • Beijing, China
      Beijing Tsinghua Changgung Hospital
    2021-02-02
    Feb 2, 2021
    M
    Completed
    • Hepatitis C, Chronic
    • Vaniprevir 600 mg b.i.d.
    • +3 more
    • (no location specified)
    2021-01-15
    Jan 15, 2021
    M
    Completed
    • Bone Marrow Transplant Infection
    • +5 more
    • Ribavirin
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2021-01-21
    Jan 21, 2021
    T
    Recruiting
    • Covid19
    • Interferon beta-1b
    • Ribavirin
    • Hong Kong, Hong Kong
      The University of Hong Kong, Queen Mary Hospital
    2020-07-29
    Jul 29, 2020
    M
    Active, not recruiting
    • BCLC Stage B Hepatocellular Carcinoma
    • +10 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-02-25
    Feb 25, 2022
    N
    Completed
    • Hepatitis C Infection
    • HIV Infection
    • Nitazoxanide With Pegylated Interferon And Ribavirin
    • Washington, District of Columbia
    • +3 more
    2021-09-14
    Sep 14, 2021
    P
    Completed
    • Chronic Hepatitis C Virus Infection
    • P1101 + Ribavirin
    • PEG-Intron + Ribavirin
    • Beijing, China
    • +38 more
    2022-01-14
    Jan 14, 2022
    M
    Not yet recruiting
    • COVID
    • Drug Effect
    • Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :
    • Mansoura, Select A State Or Province, Egypt
      Mansoura University
    2020-09-01
    Sep 1, 2020